Dimensional Fund Advisors’s Aerie Pharmaceuticals AERI Stock Holding History

Dimensional Fund Advisors’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-57,095	Closed	-$1.02M	–	3488
2021 Q1	$1.02M	Sell	57,095 -13,684	-19%	-$236K	﹤0.01%	3013
2020 Q4	$956K	Hold	70,779	–	–	﹤0.01%	2986
2020 Q3	$833K	Hold	70,779	–	–	﹤0.01%	2969
2020 Q2	$1.04M	Buy	70,779 +1,554	+2%	+$23K	﹤0.01%	2930
2020 Q1	$935K	Buy	69,225 +46,011	+198%	+$873K	﹤0.01%	2918
2019 Q4	$561K	Buy	+23,214	New	+$481K	﹤0.01%	3119

Other funds holding AERI

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Dimensional Fund Advisors's AERI Position: Q2 2021 in Review

Dimensional Fund Advisors sold out of Aerie Pharmaceuticals (AERI) in Q2 2021, closing a stake of 57,095 shares — an estimated $1.02M sold.

Dimensional Fund Advisors first reported a position in AERI in Q4 2019 and held it in 6 quarters. The position peaked at $1.04M in Q2 2020. 142 funds tracked by Wall St. Rank hold AERI as of Q2 2021.

Dimensional Fund Advisors reported no remaining Aerie Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
Dimensional Fund Advisors sold 57,095 Aerie Pharmaceuticals shares in Q2 2021, an estimated $1.02M.
Dimensional Fund Advisors first reported a position in Aerie Pharmaceuticals in Q4 2019 and held it in 6 quarters.
Dimensional Fund Advisors's Aerie Pharmaceuticals position peaked at $1.04M in Q2 2020.
142 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2021.

Based on Dimensional Fund Advisors's 13F filing for Q2 2021, filed 12 Aug 2021.